XT
ENTA icon

XTX Topco’s Enanta Pharmaceuticals ENTA Stock Holding History

XTX Topco’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$419K Buy
+33,211
New +$445K 0.01% 2201
2025
Q2 		– Sell
-19,941
Closed -$110K – 2564
2025
Q1 		$110K Buy
+19,941
New +$123K 0.01% 1851
2024
Q2 		– Sell
-14,282
Closed -$249K – 2025
2024
Q1 		$249K Sell
14,282
-1,689
-11% -$22.3K 0.03% 1004
2023
Q4 		$150K Sell
15,971
-11,251
-41% -$105K 0.03% 1042
2023
Q3 		$304K Buy
27,222
+15,380
+130% +$248K 0.05% 721
2023
Q2 		$253K Buy
+11,842
New +$349K 0.05% 839

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

XTX Topco's ENTA Position: Q1 2026 in Review

XTX Topco opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 33,211 shares worth $419K. The stake represents 0.01% of the portfolio and ranks #2201 among its holdings. This is a return to the name: XTX Topco previously reported a position in ENTA as recently as Q1 2025.

XTX Topco first reported a position in ENTA in Q2 2023 and has held it in 6 quarters since. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • XTX Topco held 33,211 shares of Enanta Pharmaceuticals worth $419K as of Q1 2026.
  • Enanta Pharmaceuticals was a new XTX Topco position in Q1 2026.
  • Enanta Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2201 holding.
  • XTX Topco first reported a position in Enanta Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.